Viewing Study NCT02704156

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:28 PM
Ignite Modification Date: 2026-03-29 @ 3:21 PM
Study NCT ID: NCT02704156
Status: COMPLETED
Last Update Posted: 2022-05-13
First Post: 2016-03-01
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: SBRT Plus Pembrolizumab and Trametinib for Pancreatic Cancer
Sponsor: Changhai Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Stereotactic body radiation therapy View
None CyberKnife View
None Initial treatment View